1. Home
  2. GSRT vs HRTX Comparison

GSRT vs HRTX Comparison

Compare GSRT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSRT
  • HRTX
  • Stock Information
  • Founded
  • GSRT 2023
  • HRTX 1983
  • Country
  • GSRT United States
  • HRTX United States
  • Employees
  • GSRT N/A
  • HRTX N/A
  • Industry
  • GSRT
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSRT
  • HRTX Health Care
  • Exchange
  • GSRT Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • GSRT 302.2M
  • HRTX 276.1M
  • IPO Year
  • GSRT 2024
  • HRTX 1987
  • Fundamental
  • Price
  • GSRT $10.37
  • HRTX $1.35
  • Analyst Decision
  • GSRT Strong Buy
  • HRTX Strong Buy
  • Analyst Count
  • GSRT 1
  • HRTX 2
  • Target Price
  • GSRT $19.00
  • HRTX $4.50
  • AVG Volume (30 Days)
  • GSRT 518.2K
  • HRTX 2.6M
  • Earning Date
  • GSRT 01-01-0001
  • HRTX 08-08-2025
  • Dividend Yield
  • GSRT N/A
  • HRTX N/A
  • EPS Growth
  • GSRT N/A
  • HRTX N/A
  • EPS
  • GSRT 0.19
  • HRTX N/A
  • Revenue
  • GSRT N/A
  • HRTX $149,694,000.00
  • Revenue This Year
  • GSRT N/A
  • HRTX $10.62
  • Revenue Next Year
  • GSRT N/A
  • HRTX $12.99
  • P/E Ratio
  • GSRT $53.45
  • HRTX N/A
  • Revenue Growth
  • GSRT N/A
  • HRTX 9.78
  • 52 Week Low
  • GSRT $9.86
  • HRTX $1.04
  • 52 Week High
  • GSRT $11.49
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • GSRT 40.74
  • HRTX 36.48
  • Support Level
  • GSRT $10.36
  • HRTX $1.33
  • Resistance Level
  • GSRT $10.40
  • HRTX $1.43
  • Average True Range (ATR)
  • GSRT 0.08
  • HRTX 0.07
  • MACD
  • GSRT 0.01
  • HRTX 0.02
  • Stochastic Oscillator
  • GSRT 14.67
  • HRTX 45.45

About GSRT GSR III Acquisition Corp. Ordinary Shares

GSR III Acquisition Corp is a blank check company.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: